A detailed history of Mc Adam, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Mc Adam, LLC holds 11,206 shares of MRNA stock, worth $413,949. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,206
Previous 11,075 1.18%
Holding current value
$413,949
Previous $1.32 Million 43.12%
% of portfolio
0.04%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$63.64 - $125.14 $8,336 - $16,393
131 Added 1.18%
11,206 $748,000
Q2 2024

Jul 24, 2024

BUY
$101.21 - $166.61 $11,841 - $19,493
117 Added 1.07%
11,075 $1.32 Million
Q1 2024

Apr 23, 2024

SELL
$85.37 - $115.44 $3,329 - $4,502
-39 Reduced 0.35%
10,958 $1.17 Million
Q4 2023

Feb 05, 2024

BUY
$69.51 - $104.43 $175,790 - $264,103
2,529 Added 29.87%
10,997 $1.09 Million
Q3 2023

Oct 31, 2023

BUY
$96.41 - $126.61 $54,182 - $71,154
562 Added 7.11%
8,468 $874,000
Q2 2023

Aug 02, 2023

BUY
$118.5 - $160.53 $129,402 - $175,298
1,092 Added 16.03%
7,906 $960,000
Q1 2023

Apr 24, 2023

BUY
$135.66 - $197.02 $419,732 - $609,579
3,094 Added 83.17%
6,814 $1.05 Million
Q4 2022

Jan 27, 2023

SELL
$118.38 - $210.04 $165,613 - $293,845
-1,399 Reduced 27.33%
3,720 $945,000
Q3 2022

Oct 24, 2022

BUY
$118.07 - $194.18 $89,024 - $146,411
754 Added 17.27%
5,119 $605,000
Q2 2022

Jul 15, 2022

BUY
$117.13 - $176.59 $18,623 - $28,077
159 Added 3.78%
4,365 $624,000
Q1 2022

Apr 07, 2022

BUY
$126.46 - $235.05 $61,459 - $114,234
486 Added 13.06%
4,206 $725,000
Q4 2021

Jan 07, 2022

BUY
$225.82 - $368.51 $301,695 - $492,329
1,336 Added 56.04%
3,720 $945,000
Q3 2021

Oct 05, 2021

SELL
$221.9 - $484.47 $4,881 - $10,658
-22 Reduced 0.91%
2,384 $918,000
Q2 2021

Aug 02, 2021

BUY
$129.91 - $234.98 $13,770 - $24,907
106 Added 4.61%
2,406 $832,000
Q1 2021

Apr 26, 2021

BUY
$109.18 - $185.98 $251,114 - $427,754
2,300 New
2,300 $301,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Mc Adam, LLC Portfolio

Follow Mc Adam, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.